Medical Oxygen Concentrators are devices that extract oxygen from the air and concentrate it for delivery to patients who need it. These devices are critical for patients with respiratory illnesses such as COPD, pneumonia, and asthma. The market for medical oxygen concentrators has been growing steadily in recent years due to the increasing incidence of respiratory diseases and the aging population.
North America held the largest market share in 2020 due to the presence of a large patient pool and increasing healthcare expenditure. The Asia-Pacific region is expected to witness the highest CAGR during the forecast period due to the rising incidence of respiratory diseases and increasing healthcare infrastructure.medical oxygen concentrators is expected to reach ~$3.94 billion by 2028, growing at a CAGR of +9% from 2021 to 2028
Invacare Corporation;
Philips Respironics
Inogen, Inc.
Caire Inc.
DeVilbiss Healthcare LLC.
ResMed
OxyGo, LLC.
The major trends in the medical oxygen concentrators market include the increasing adoption of portable oxygen concentrators, technological advancements, and the development of online sales channels. The key drivers of the market are the rising incidence of respiratory diseases, increasing geriatric population, and the growing demand for home healthcare services.
The opportunities in the medical oxygen concentrators market include the increasing demand for portable oxygen concentrators, the rising adoption of home healthcare services, and the increasing healthcare expenditure. The threats to the market include the availability of alternative therapies, stringent regulatory requirements, and the high cost of devices.
The medical oxygen concentrators market is subject to various regulatory and legal issues. For instance, the US Food and Drug Administration (FDA) regulates the safety and efficacy of medical devices, including oxygen concentrators. In addition, medical oxygen concentrators are subject to various quality standards, such as the International Organization for Standardization (ISO) and the European Committee for Standardization (CEN).
The target demographics of the medical oxygen concentrators market include patients with respiratory diseases, particularly those with COPD, pneumonia, and asthma. The preferences and behaviors of these patients vary depending on their age, gender, income, and geographic location. For instance, older patients may prefer home healthcare services and portable oxygen concentrators, while younger patients may prefer traditional oxygen concentrators.
The pricing trends in the medical oxygen concentrators market vary across different segments. Portable oxygen concentrators are generally more expensive than traditional oxygen concentrators due to their advanced technology and convenience. In addition, the pricing of medical oxygen concentrators is subject to various factors such as competition, raw material costs, and regulatory requirements.
In conclusion, the medical oxygen concentrators market is expected to grow steadily in the coming years due to the increasing incidence of respiratory diseases and the aging population. The market is highly competitive, with key players focusing on expanding their product portfolios and distribution networks. The major trends and drivers of the market include the increasing adoption of portable oxygen concentrators, technological advancements, and the development of online sales channels.
Invacare Corporation;
Philips Respironics
Inogen, Inc.
Caire Inc.
DeVilbiss Healthcare LLC.
ResMed
OxyGo, LLC.
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
AI® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2025-26 AI® Market Research and Consulting. All Rights Reserved | Designed by AI® Market